US Patent Issued to STCUBE & Co. on Feb. 4 for "Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1" (Virginia, Maryland Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,151, issued on Feb. 4, was assigned to STCUBE & Co. INC. (Seoul, South Korea).

"Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1" was invented by Stephen Sunghan Yoo (Centreville, Va.), Yong-Sik Bong (Frederick, Md.), Kyu Lee Han (Frederick, Md.) and Michael Joseph Surace (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for treating cancer using molecules having an antigen binding fragment that immunospecifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immunospecifically binds to gly...